Generic name : Cabozantinib.
Trade name : Cometriq.
Manufacturer information :
Cometriq is manufactured by Exelixis, Inc.
Cometriq FDA Approval :
Cometriq first approved November 29th, 2012.
Cometriq Dosage form :
20 mg and 80 mg capsules.
Cometriq Indications and Usage :
Medullary Thyroid Cancer
Indicated for treatment of progressive, metastatic medullary thyroid cancer.
Cometriq (Cabozantinib) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.